Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4196.89x is 422% below its 3-year average of -804.57x, near the low end of its 3-year range (-4196.89x–-0.30x).
As of the fiscal period ended Sunday, June 30, 2019. 65.80% below its 12-month average of -2531.31x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2019 (2019-06-30): -4196.89x.
INTEREST COVERAGE RATIO
-4196.89x
INTEREST COVERAGE RATIO AVG TTM
-2531.31x
INTEREST COVERAGE RATIO AVG 3Y
-804.57x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-65.80%
CURRENT VS 3Y AVG
-421.63%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-72385.20%
vs the sector median at left
enVVeno Medical Corporation
Market Cap
$5.77M
Interest Coverage Ratio
-4196.89x
TTM Avg
-2531.31x
3Y Avg
-804.57x
5Y Avg
N/A
Market Cap
$5.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.70M
Interest Coverage Ratio
-310.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.92M
Interest Coverage Ratio
-3.98x
TTM Avg
2.35x
3Y Avg
2.44x
5Y Avg
2.44x
Market Cap
$5.98M
Interest Coverage Ratio
-438.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.93M
Interest Coverage Ratio
-1153.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.77M | -4196.89x | -2531.31x | -804.57x | N/A |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.79M | N/A | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.82M | N/A | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.70M | -310.21x | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.61M | N/A | N/A | N/A | N/A |
| Scienture Holdings, Inc. (SCNX)vs › | $5.92M | -3.98x | 2.35x | 2.44x | 2.44x |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -438.08x | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.93M | -1153.85x | N/A | N/A | N/A |
| Pulmatrix, Inc. (PULM)vs › | $5.41M | N/A | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.31M | -1174.37x | N/A | N/A | N/A |
Interest Coverage
-4196.9x
Debt/Equity
0.02
Current Ratio
11.70
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2019-06-30 | -4196.89x |
| 2019-03-31 | -3395.58x |
| 2018-06-30 | -1.47x |
| 2018-03-31 | -0.30x |
| 2017-12-31 | -1.35x |
| 2017-09-30 | -4.06x |
| 2017-06-30 | -31.33x |
| 2017-03-31 | -122.20x |
| 2016-12-31 | -218.83x |
| 2016-09-30 | -73.70x |
